vaccines
Merck joins coalition for biosecurity vaccine plant
March 22, 2010Manufacturing and Production, Research and Development biodefence, vaccines
Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …
Immatics vaccine trials to be conducted with Cancer Research UK
February 16, 2010Research and Development immatics, vaccines
Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …
Pfizer to personalise brain tumour vaccine
February 8, 2010Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines
Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
Lancet retracts MMR research conclusions
February 3, 2010Research and Development MMR, Sanofi, vaccines
The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …
Gates’ $10 billion vaccines pledge to cut child mortality
February 1, 2010Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines
Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …
UK poised for shingles vaccination programme
February 1, 2010shingles, vaccines
The government is to undertake what it calls “a rigorous procurement programme” to look for a suitable shingles vaccine. Possibilities …
Sanofi Pasteur collaborates on novel biologics
January 12, 2010Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
Dr Julie Gerberding appointed to head up Merck Vaccines
January 6, 2010Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines
Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
GSK signs needle-free vaccine alliance
December 16, 2009Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines
GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …
Sanofi invests in syringe production in France
December 16, 2009Manufacturing and Production France, Sanofi-Aventis, vaccines
Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …
GSK licences smoking vaccine candidate
November 30, 2009Research and Development GSK, Nabi, smoking, vaccines
GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …
Novartis opens $1bn flu vaccine plant
November 25, 2009Manufacturing and Production Novartis, US, vaccines
Novartis has opened a new $1 billion vaccine manufacturing plant that is the first to be set up as a …
GSK expands in China with vaccine joint venture
October 12, 2009Sales and Marketing China, GSK, vaccines
GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …
GSK agrees more government orders for H1N1 vaccine
October 7, 2009Sales and Marketing GSK, h1n1, vaccines
GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …
Cervarix not to blame for UK post-vaccination death
October 5, 2009Sales and Marketing Cervarix, NHS, reg, vaccines
The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
